{"transactions":[{"id":4634570,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Voting Common Stock","published_at":"2026-10-03T00:45:32.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"25% of the restricted stock units (\"RSUs\") shall vest on September 30, 2028, with the remaining 75% of the RSUs vesting on the earlier of (i) reporting of completion of the pivotal trial of TSC-101, or (ii) September 30, 2030, subject to continued service with the Issuer through the applicable vesting dates and the terms of the Issuer's Amended and Restated 2021 Equity Incentive Plan and the applicable award agreement."}],"balance_after":304716,"source":{"system":"sec-edgar","filing":"0001193125-26-412518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000119312526412518/ownership.xml","form_type":"4"}},{"id":933444,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-22T22:19:41.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 20, 2026, with the balance vesting thereafter in equal monthly installments over the next 36 months, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":350000,"derivative":{"exercise_price":1.12,"expiration_date":"2036-01-20","underlying":"Voting Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001193125-26-019674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000119312526019674/ownership.xml","form_type":"4"}},{"id":1274090,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T22:54:41.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 3, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer."}],"balance_after":250000,"derivative":{"exercise_price":3.065,"expiration_date":"2035-01-03","underlying":"Voting Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-25-018131","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017025018131/ownership.xml","form_type":"4"}},{"id":1274089,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T22:54:41.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 12, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer."}],"balance_after":52500,"derivative":{"exercise_price":6,"expiration_date":"2034-01-12","underlying":"Voting Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0000950170-25-018131","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017025018131/ownership.xml","form_type":"4"}},{"id":1421978,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-27T22:46:50.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":false,"shares":64166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"220,000 shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of May 24, 2023, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer. The remaining 210,000 shares subject to this option shall vest and become exercisable with respect to 25% of the shares on February 2, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer, in each case subject to the Reporting Person's continued service at such time. This option was granted on May 24, 2023 subject to the approval of the Issuers' stockholders of an amendment to the TScan Therapeutics, Inc. 2021 Equity Incentive Plan, which was obtained on June 13, 2023."}],"balance_after":365834,"derivative":{"exercise_price":2.49,"expiration_date":"2033-06-12","underlying":"Voting Common Stock","underlying_shares":64166},"source":{"system":"sec-edgar","filing":"0000950170-24-101161","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017024101161/ownership.xml","form_type":"4"}},{"id":1421977,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-27T22:46:50.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":false,"shares":13125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option vest over 4 years of service following February 2, 2023, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":21875,"derivative":{"exercise_price":1.81,"expiration_date":"2033-02-01","underlying":"Voting Common Stock","underlying_shares":13125},"source":{"system":"sec-edgar","filing":"0000950170-24-101161","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017024101161/ownership.xml","form_type":"4"}},{"id":1421976,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-27T22:46:50.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option vest over 4 years of service following July 25, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":25000,"derivative":{"exercise_price":3.27,"expiration_date":"2032-07-24","underlying":"Voting Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-101161","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017024101161/ownership.xml","form_type":"4"}},{"id":1421975,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-27T22:46:50.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":false,"shares":54895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest over 4 years of service following January 18, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":30105,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-17","underlying":"Voting Common Stock","underlying_shares":54895},"source":{"system":"sec-edgar","filing":"0000950170-24-101161","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017024101161/ownership.xml","form_type":"4"}},{"id":1421974,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Voting Common Stock","published_at":"2024-08-27T22:46:50.000Z","date":"2024-08-23","kind":"sale","planned":false,"acquired":false,"shares":164686,"price":5.7814,"value":952115.6404,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.56 to $5.91, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request."}],"balance_after":4716,"source":{"system":"sec-edgar","filing":"0000950170-24-101161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017024101161/ownership.xml","form_type":"4"}},{"id":1421973,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Voting Common Stock","published_at":"2024-08-27T22:46:50.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":true,"shares":64166,"price":2.49,"value":159773.34,"ownership":{"direct":true},"balance_after":169402,"source":{"system":"sec-edgar","filing":"0000950170-24-101161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017024101161/ownership.xml","form_type":"4"}},{"id":1421972,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Voting Common Stock","published_at":"2024-08-27T22:46:50.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":true,"shares":13125,"price":1.81,"value":23756.25,"ownership":{"direct":true},"balance_after":105236,"source":{"system":"sec-edgar","filing":"0000950170-24-101161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017024101161/ownership.xml","form_type":"4"}},{"id":1421971,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Voting Common Stock","published_at":"2024-08-27T22:46:50.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":3.27,"value":81750.0,"ownership":{"direct":true},"balance_after":92111,"source":{"system":"sec-edgar","filing":"0000950170-24-101161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017024101161/ownership.xml","form_type":"4"}},{"id":1421970,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Voting Common Stock","published_at":"2024-08-27T22:46:50.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":true,"shares":54895,"price":4.85,"value":266240.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,500 shares of Voting Common Stock acquired under the TScan Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 31, 2022."}],"balance_after":67111,"source":{"system":"sec-edgar","filing":"0000950170-24-101161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000095017024101161/ownership.xml","form_type":"4"}},{"id":1854477,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T22:01:48.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":430000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"220,000 shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of May 24, 2023, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer. The remaining 210,000 shares subject to this option shall vest and become exercisable with respect to 25% of the shares on February 2, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer, in each case subject to the Reporting Person's continued service at such time. This option was granted on May 24, 2023 subject to the approval of the Issuers' stockholders of an amendment to the TScan Therapeutics, Inc. 2021 Equity Incentive Plan, which was obtained on June 13, 2023."}],"balance_after":430000,"derivative":{"exercise_price":2.49,"expiration_date":"2033-06-12","underlying":"Voting Common Stock","underlying_shares":430000},"source":{"system":"sec-edgar","filing":"0000899243-23-015632","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924323015632/doc4.xml","form_type":"4"}},{"id":2030675,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-06T22:15:50.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over 4 years of service following February 2, 2023, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":35000,"derivative":{"exercise_price":1.81,"expiration_date":"2033-02-01","underlying":"Voting Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-23-004064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924323004064/doc4.xml","form_type":"4"}},{"id":2201375,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-27T20:30:37.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over 4 years of service following July 25, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":3.27,"expiration_date":"2032-07-24","underlying":"Voting Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-22-026847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924322026847/doc4.xml","form_type":"4"}},{"id":2430694,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:25:22.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over 4 years of service following January 18, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":85000,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-17","underlying":"Voting Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0000899243-22-002646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924322002646/doc4.xml","form_type":"4"}},{"id":2558938,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Voting Common Stock","published_at":"2021-09-27T21:22:04.000Z","date":"2021-09-23","kind":"purchase","acquired":true,"shares":4716,"price":7.4757,"value":35255.4012,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $7.43 to $7.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":4716,"source":{"system":"sec-edgar","filing":"0000899243-21-037802","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924321037802/doc4.xml","form_type":"4"}},{"id":2574864,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-09T21:21:59.000Z","date":"2021-09-07","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest with respect to 25% of the shares after 12 months of continuous service to the Issuer following September 7, 2021, and the balance will vest in equal monthly installments over the next 36 months of continuous service to the Issuer."}],"balance_after":150000,"derivative":{"exercise_price":8.99,"expiration_date":"2031-09-06","underlying":"Voting Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-21-035470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783328/000089924321035470/doc4.xml","form_type":"4"}},{"id":2859237,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-16T22:47:41.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":67700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2021."}],"balance_after":67700,"derivative":{"exercise_price":10.8,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":67700},"source":{"system":"sec-edgar","filing":"0000899243-21-006713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924321006713/doc4.xml","form_type":"4"}},{"id":3277176,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-12T22:11:22.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2020."}],"balance_after":60000,"derivative":{"exercise_price":12.28,"expiration_date":"2030-02-09","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-20-004308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924320004308/doc4.xml","form_type":"4"}},{"id":3329817,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-30T22:39:35.000Z","date":"2019-12-24","kind":"exercise","acquired":false,"shares":820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were not previously reported on the form 4 filed 12/26/2019 as an option exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option vests and becomes exercisable in 16 equal quarterly installments beginning on January 1, 2018."}],"balance_after":16856,"derivative":{"exercise_price":7.71,"expiration_date":"2028-01-30","underlying":"Common Stock","underlying_shares":820},"source":{"system":"sec-edgar","filing":"0001562180-19-006291","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000156218019006291/primarydocument.xml","form_type":"4/A","original_submission_date":"2019-12-26"}},{"id":3329816,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-30T22:39:35.000Z","date":"2019-12-23","kind":"exercise","acquired":false,"shares":9,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were not previously reported on the form 4 filed 12/26/2019 as an option exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option vests and becomes exercisable in 16 equal quarterly installments beginning on January 1, 2018."}],"balance_after":17676,"derivative":{"exercise_price":7.71,"expiration_date":"2028-01-30","underlying":"Common Stock","underlying_shares":9},"source":{"system":"sec-edgar","filing":"0001562180-19-006291","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000156218019006291/primarydocument.xml","form_type":"4/A","original_submission_date":"2019-12-26"}},{"id":3329815,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-30T22:39:35.000Z","date":"2019-12-23","kind":"exercise","acquired":false,"shares":4172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were not previously reported on the form 4 filed 12/26/2019 as an option exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option vests and becomes exercisable in 48 equal monthly installments beginning on the date of effectiveness of the Issuer's Registration Statement on Form S-1."}],"balance_after":129342,"derivative":{"exercise_price":9.49,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":4172},"source":{"system":"sec-edgar","filing":"0001562180-19-006291","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000156218019006291/primarydocument.xml","form_type":"4/A","original_submission_date":"2019-12-26"}},{"id":3329814,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-12-30T22:39:35.000Z","date":"2019-12-24","kind":"sale","acquired":false,"shares":7902,"price":16,"value":126432.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This trade is pursuant to an active 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $16.00 to $16.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request by the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Balance has been updated to reflect the shares acquired and sold on the form 4 filed 12/26/2019."}],"balance_after":133010,"source":{"system":"sec-edgar","filing":"0001562180-19-006291","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000156218019006291/primarydocument.xml","form_type":"4/A","original_submission_date":"2019-12-26"}},{"id":3329813,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-12-30T22:39:35.000Z","date":"2019-12-24","kind":"exercise","acquired":true,"shares":820,"price":7.71,"value":6322.2,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Shares were not previously reported on the form 4 filed 12/26/2019 as an option exercise."}],"balance_after":140912,"source":{"system":"sec-edgar","filing":"0001562180-19-006291","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000156218019006291/primarydocument.xml","form_type":"4/A","original_submission_date":"2019-12-26"}},{"id":3329812,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-12-30T22:39:35.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":4181,"price":16.0347,"value":67041.0807,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This trade is pursuant to an active 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $16.00 to $16.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":140092,"source":{"system":"sec-edgar","filing":"0001562180-19-006291","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000156218019006291/primarydocument.xml","form_type":"4/A","original_submission_date":"2019-12-26"}},{"id":3329811,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-12-30T22:39:35.000Z","date":"2019-12-23","kind":"exercise","acquired":true,"shares":4172,"price":9.49,"value":39592.28,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Shares were not previously reported on the form 4 filed 12/26/2019 as an option exercise."}],"balance_after":144273,"source":{"system":"sec-edgar","filing":"0001562180-19-006291","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000156218019006291/primarydocument.xml","form_type":"4/A","original_submission_date":"2019-12-26"}},{"id":3329810,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-12-30T22:39:35.000Z","date":"2019-12-23","kind":"exercise","acquired":true,"shares":9,"price":7.71,"value":69.39,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Shares were not previously reported on the form 4 filed 12/26/2019 as an option exercise."}],"balance_after":140101,"source":{"system":"sec-edgar","filing":"0001562180-19-006291","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000156218019006291/primarydocument.xml","form_type":"4/A","original_submission_date":"2019-12-26"}},{"id":3331326,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-12-26T21:11:54.000Z","date":"2019-12-24","kind":"sale","acquired":false,"shares":7902,"price":16,"value":126432.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This trade is pursuant to an active 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $16.00 to $16.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":128009,"source":{"system":"sec-edgar","filing":"0001562180-19-006265","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000156218019006265/primarydocument.xml","form_type":"4"}},{"id":3331325,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-12-26T15:13:05.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":4181,"price":16.03,"value":67021.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This trade is pursuant to an active 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $16.00 to $16.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":135911,"source":{"system":"sec-edgar","filing":"0001562180-19-006261","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000156218019006261/primarydocument.xml","form_type":"4"}},{"id":3670470,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-07T21:23:39.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 equal quarterly installments beginning on January 1, 2019."}],"balance_after":80000,"derivative":{"exercise_price":7.13,"expiration_date":"2029-02-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000899243-19-002874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924319002874/doc4.xml","form_type":"4"}},{"id":3882361,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series C Preferred Stock","published_at":"2018-06-27T20:30:30.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Preferred Stock converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Preferred Stock converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Preferred Stock converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Series C Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4643},"source":{"system":"sec-edgar","filing":"0000899243-18-018332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318018332/doc4.xml","form_type":"4"}},{"id":3882360,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":68999,"kind":"person","name":"ZDRAVESKI ZORAN","position":1,"cik":"0001741285","reported_name":"ZDRAVESKI ZORAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-27T20:30:30.000Z","date":"2018-06-25","kind":"exercise","acquired":true,"shares":4643,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock converted into Common Stock on a 2.58398:1 basis upon the closing of the Issuer's initial public offering on June 25, 2018. The Series C Preferred Stock had no expiration date."}],"balance_after":140092,"source":{"system":"sec-edgar","filing":"0000899243-18-018332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924318018332/doc4.xml","form_type":"4"}}]}